Yu Katayose
Impact in
Papers in
- Co-authors
- Michiaki Unno (114 shared papers)Shinichi Egawa (61 shared papers)Fuyuhiko Motoi (65 shared papers)Toshiki Rikiyama (44 shared papers)Takeshi Naitoh (24 shared papers)Prem K. Seth (6 shared papers)Amol N.S. Rakkar (5 shared papers)Kenneth H. Cowan (6 shared papers)
- Journals
- Surgery Today (7 papers)Biochemical and Biophysical Research Communications (5 papers)Cancer Science (4 papers)Journal of Hepato-Biliary-Pancreatic Sciences (4 papers)Pancreatology (4 papers)
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Yu Katayose
145 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 108
- Oncology 1.6k
- Surgery 1.0k
- Cancer Research 306
- Radiology, Nuclear Medicine and Imaging 414
- Pulmonary and Respiratory Medicine 482
Countries citing papers authored by Yu Katayose
This map shows the geographic impact of Yu Katayose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Katayose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Katayose more than expected).
Fields of papers citing papers by Yu Katayose
This network shows the impact of papers produced by Yu Katayose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Katayose. The network helps show where Yu Katayose may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu Katayose, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 158 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27. | 1997 | 291 |
| 2 | 2015 | 223 | |
| 3 | 2012 | 178 | |
| 4 | 2013 | 130 | |
| 5 | 1995 | 129 | |
| 6 | 2013 | 87 | |
| 7 | 2009 | 82 | |
| 8 | 2007 | 81 | |
| 9 | Clock gene mouse period2 overexpression inhibits growth of human pancreatic cancer cells and has synergistic effect with cisplatin. | 2009 | 70 |
| 10 | 2023 | 66 | |
| 11 | 2012 | 61 | |
| 12 | 2007 | 60 | |
| 13 | 2006 | 60 | |
| 14 | 2009 | 56 | |
| 15 | 2022 | 53 | |
| 16 | 2014 | 52 | |
| 17 | 2007 | 52 | |
| 18 | 1998 | 51 | |
| 19 | 2010 | 47 | |
| 20 | 2010 | 47 |
About Yu Katayose
Yu Katayose is a scholar working on Oncology, Surgery, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Hepatology, having authored 158 papers that have together received 3.7k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (28 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (21 papers), Monoclonal and Polyclonal Antibodies Research (20 papers), Glycosylation and Glycoproteins Research (13 papers), Pancreatitis Pathology and Treatment (13 papers), Pancreatic function and diabetes (12 papers), Gallbladder and Bile Duct Disorders (11 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). The work is most often cited by research in Oncology (1.6k citations), Surgery (1.0k citations), Cancer Research (306 citations), Radiology, Nuclear Medicine and Imaging (414 citations) and Pulmonary and Respiratory Medicine (482 citations). Yu Katayose has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Michiaki Unno, Shinichi Egawa, Fuyuhiko Motoi, Toshiki Rikiyama, Takeshi Naitoh, Prem K. Seth, Amol N.S. Rakkar, Kenneth H. Cowan, Hiroki Hayashi and Tatsuo Hata. Their work appears in journals such as Surgery Today, Biochemical and Biophysical Research Communications, Cancer Science, Journal of Hepato-Biliary-Pancreatic Sciences and Pancreatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.